CS logo
small CS logo
Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital

Hangzhou, China
Hospital in Hangzhou
Zhejiang, Hangzhou, Jianggan District, 城东庆春东路3号 邮政编码 - 310016
1,200 Beds

About Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital


Sir Run Run Shaw Hospital, or Shao Yifu Hospital, is a hospital affiliated with the Medical School of Zhejiang University, in Hangzhou, Zhejiang, China.
There are 1,200 beds in Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
5
Beijing Chao Yang Hospital
2
Sir Run Run Shaw Hospital
2
Changlin Mei
1
Daehwa Pharmaceutical Co., Ltd.
1
Jiangsu HengRui Medicine Co., Ltd.
1
Pierre Fabre Medicament
1
Shanghai Junshi Bioscience Co., Ltd.
1
Taizhou Hanzhong biomedical co. LTD
1
Total Rows: 9

Clinical Trials at Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital


During the past decade, Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2211220022221100000022000000Started TrialsCompleted Trails20162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
2002-06-01
2006-02-01
Completed
274
12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China
2002-06-01
2006-02-01
Completed
129
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
The Effectiveness of Early Botulinum Toxin A Injection for Lower Limbs Spasticity in Subacute Stroke Adults
2014-01-01
2017-01-01
Unknown status
30
Botulinum Toxin A for Shoulder Pain After Stroke
2016-02-01
2018-12-01
Unknown status
50
Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical Trial
2016-09-02
2020-12-31
Completed
459
Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy
2017-12-18
2022-03-31
Unknown status
476

Rows per page:

1–15 of 15

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Beijing Chao Yang Hospital" with 2 trials sponsored, "Sir Run Run Shaw Hospital" with 2 trials sponsored, "Changlin Mei" with 1 trials sponsored and "Daehwa Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 1 trials as a collaborator, "Fuzhou General Hospital" with 1 trials as a collaborator, "Hebei Medical University Third Hospital" with 1 trials as a collaborator and "Hebei Province Center for Reproductive Medicine" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 5Boehringer Ingelheim: 5Beijing Chao Yang Hospital: 2Beijing Chao Yang Hospital: 2Sir Run Run Shaw Hospital: 2Sir Run Run Shaw Hospital: 2Changlin Mei: 1Changlin Mei: 1Daehwa PharmaceuticalCo., Ltd.: 1Daehwa PharmaceuticalCo., Ltd.: 1Jiangsu HengRuiMedicine Co., Ltd.: 1Jiangsu HengRuiMedicine Co., Ltd.: 1Pierre Fabre Medicament: 1Pierre Fabre Medicament: 1Shanghai JunshiBioscience Co., Ltd.: 1Shanghai JunshiBioscience Co., Ltd.: 1Taizhou Hanzhongbiomedical co. LTD: 1Taizhou Hanzhongbiomedical co. LTD: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2First Affiliated Hospital,Sun Yat-Sen University:1First Affiliated Hospital,Sun Yat-Sen University:1Fuzhou General Hospital: 1Fuzhou General Hospital: 1Hebei MedicalUniversity ThirdHospital: 1Hebei MedicalUniversity ThirdHospital: 1Hebei Province Centerfor ReproductiveMedicine: 1Hebei Province Centerfor ReproductiveMedicine: 1Hospital forReproductive MedicineAffiliated to ShandongUniversity: 1Hospital forReproductive MedicineAffiliated to ShandongUniversity: 1LanZhou University: 1LanZhou University: 1Navy General Hospital,Beijing: 1Navy General Hospital,Beijing: 1Peking University ThirdHospital: 1Peking University ThirdHospital: 1Renmin Hospital ofWuhan University: 1Renmin Hospital ofWuhan University: 1

Clinical Trials Conditions at Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital


According to Clinical.Site data, the most researched conditions in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" are "Stroke" (4 trials), "Pulmonary Embolism" (2 trials), "Thromboembolism" (2 trials), "Advanced Breast Cancer" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital


Most popular intervention types in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" are "Drug" (14 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "ASA 100 mg" (1 trials), "BI 456906" (1 trials), "Binimetinib" (1 trials) and "BoNT-A injection" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital


The vast majority of trials in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital" are 14 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital


Currently, there are NaN active trials in "Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 6Phase 2: 6Phase 4: 5Phase 4: 5Phase 3: 4Phase 3: 4Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Unknown status: 5Unknown status: 5Active, not recruiting: 3Active, not recruiting: 3Recruiting: 2Recruiting: 2